Found 26 matching trials
Expression of Toll-like Receptors 3 , 7 and 9 in Peripheral Blood Mononuclear Cells of COVID-19 Patients N/A The aim of the study is to assess the expression of TLR 3, 7, and 9 in the ...
Show More Location
Multiple Locations
Learn More & Join Trial
Cryoablation and Arterial Infusion of SD-101 in Combination With Durvalumab and Tremelimumab PHASE1 The goal of this Phase 1b clinical trial is to evaluate the safety and effi...
Show More Status
Active Not Recruiting
Location
University of California, San Diego
Learn More & Join Trial
Phase 1-2 of a CpG-Activated Whole Cell Vaccine Followed by Autologous Immunotransplant for MCL PHASE2 Mantle cell lymphoma (MCL) is a sub-type of non-Hodgkin's lymphoma (NHL) wh...
Show More Location
Stanford University Medical Center
Learn More & Join Trial
ApTOLL for the Treatment of COVID-19 PHASE1 There is a clear and urgent medical need of developing new medicinal produc...
Show More Location
Hospital Universitario de Burgos
Learn More & Join Trial
Trial to Evaluate the Safety, Tolerability, and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy Adult Volunteers PHASE1 This is a randomized, active-controlled, dose-escalation multi-center study...
Show More Location
Paratus Clinical Research Western Sydney
Learn More & Join Trial
Safety Study of SD-101 (a Novel C Type Toll-like Receptor 9 (TLR9) Agonist) for the Treatment of Chronic Hepatitis C Virus (HCV) Infection PHASE1 To determine safety, tolerability, and preliminary efficacy of escalating d...
Show More Location
Klinika Chorób Zakaźnych i Hepatologii Collegium Medicum Uniwersytet Mikołaja Kopernika
Learn More & Join Trial
Toll-like Receptor 9 Agonist Treatment in Chronic HIV-1 Infection PHASE1 Combination antiretroviral treatment (cART) effectively suppresses virus re...
Show More Location
Department for Infectious Diseases, Aarhus University Hospital
Learn More & Join Trial
PANFIRE-3 Trial: Assessing Safety and Efficacy of Irreversible Electroporation (IRE) + Nivolumab + CpG for Metastatic Pancreatic Cancer PHASE1 Irreversible electroporation is a local ablative technique used in the trea...
Show More Location
Amsterdam University Medical Centre (location VUmc)
Learn More & Join Trial
Pembrolizumab +/- SD-101 in Hormone-Naïve Oligometastatic Prostate Cancer With RT and iADT PHASE2 This is a non-comparative open-label multicenter Phase 2 clinical trial com...
Show More Location
University of California San Francisco
Learn More & Join Trial
SD-101, Nivolumab, and Radiation Therapy in Treating Patients With Chemotherapy-Refractory Metastatic Pancreatic Cancer PHASE1 This phase I trial studies the side effects of SD-101 when given together w...
Show More Location
University of California Davis Comprehensive Cancer Center
Learn More & Join Trial